Endnotes: The efficacy estimand represents efficacy had all randomized participants remained on study intervention (with possible dose interruptions and modifications) without initiating prohibited weight management treatments (and glycemic rescue therapy for glycemic endpoints only)
In some cases, these symptoms are severe, making it difficult for patients to stick with the treatment
Participants received once-weekly subcutaneous injections of retatrutide at varying doses or placebo over 24 weeks, with a structured dose-escalation period built into the protocol to improve tolerability
But heres the catch: studies suggest that without pairing these medications with healthy lifestyle habits like eating a balanced diet, staying active, and making behavioral changes weight regain is a common outcome
It combines the biological support of GLP-1 medications with the habit-building tools that keep weight off long after the dose gets smaller
For members who meet criteria, Apaly Rx then routes each prescription to the lowest net-cost eligible channel
